From the ∗Department of Experimental Therapeutics
†Cyclotron Radiochemistry Facility, The University of Texas MD Anderson Cancer Center, Houston, TX
‡BioDevelopment Solutions, LLC, Johnstown, CO
§Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Conflicts of Interest and Source of Funding: G.C.R. is a recipient of research support from FUJIFILM Healthcare, Amgen, Novartis, Bayer, Blue Earth Diagnostics, ABX, and Curium Pharma. For the remaining authors, none were declared.
Reprints: Gregory C. Ravizzini, MD, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX 77030. E-mail: [email protected].